3622-32-0

Basic information

• Product Name: 2-Chloro-4-methylbenzothiazole
• Synonyms: IFLAB-BB F1910-0001;2-CHLORO-4-METHYL-BENZOTHIOZOLE;2-CHLORO-4-METHYL-1,3-BENZOTHIAZOLE;2-CHLORO-4-METHYLBENZOTHIAZOLE;Benzothiazole, 2-chloro-4-methyl- (6CI,7CI,8CI,9CI);2-chloro-4-methylbenzo[d]thiazole
• CAS NO: 3622-32-0
• Molecular Formula: C₈H₆ClNS
• Molecular Weight: 183.66
• Product Categories: BENZOTHIAZOLE
• Mol File: 3622-32-0.mol

Chemical Properties

• Melting Point: 49-50 °C
• Boiling Point: 268.4°Cat760mmHg
• Flash Point: 116.1°C
• Appearance: /
• Density: 1.365g/cm³
• Vapor Pressure: 0.0127mmHg at 25°C
• Refractive Index: 1.67
• Storage Temp.: 2-8°C
• PKA: 0.32±0.10(Predicted)
• CAS DataBase Reference: 2-Chloro-4-methylbenzothiazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-4-methylbenzothiazole(3622-32-0)
• EPA Substance Registry System: 2-Chloro-4-methylbenzothiazole(3622-32-0)

Safety Data

• Hazardous Substances Data: 3622-32-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Chloro-4-methylbenzothiazole is used as an intermediate in the synthesis of heteroaryl sulfonamides and aminotriazole. These compounds are essential in the development of pharmaceuticals, particularly those with potential therapeutic applications. The unique chemical properties of 2-Chloro-4-methylbenzothiazole allow for the creation of novel drug candidates with improved efficacy and selectivity.
Used in Chemical Synthesis:
In the field of chemical synthesis, 2-Chloro-4-methylbenzothiazole serves as a valuable building block for the development of various organic compounds. Its reactivity and structural features make it a versatile component in the synthesis of complex molecules, including those with potential applications in materials science, agrochemicals, and other specialty chemicals.
Used in Research and Development:
Due to its unique chemical properties, 2-Chloro-4-methylbenzothiazole is also utilized in research and development settings. It can be employed as a model compound to study various chemical reactions and mechanisms, contributing to the advancement of scientific knowledge in organic chemistry and related fields.

InChI:InChI=1/C8H6ClNS/c1-5-3-2-4-6-7(5)10-8(9)11-6/h2-4H,1H3

Upstream product

• 1477-42-5 4-methyl-1,3-benzothiazol-2-amine 
• 20174-68-9 4-methyl-2-hydrazinobenzothiazole 

Downstream Products

• 20174-68-9 4-methyl-2-hydrazinobenzothiazole 
• 3622-20-6 4-methyl-2-methylsulfanyl-1,3-benzothiazole 
• 1095340-76-3 N-(4-(4-methylbenzo[d]thiazol-2-yl)phenyl)-1-(thiophen-2-ylsulfonyl)piperidine-4-carboxamide 
• 1340598-21-1 N-{2-[4-(aminosulfonyl)phenyl]ethyl}-1-(4-methyl-1,3-benzothiazol-2-yl)-3-piperidinecarboxamide 

Relevant articles and documents

DERIVATIVES OF HETEROARYLSULFONAMIDES, THEIR PREPARATION AND THEIR APPLICATION IN HUMAN THERAPY

The present invention concerns derivatives of heteroarylsulfonamides, notably as blockers of Kv potassium channels, and more particularly of channels Kv1.5, Kv4.3 or Kv11.1, their application in clinical therapy and their preparation methods. These compounds correspond to the following general formula (I): where R1 represents one or more substituents of the phenyl core X such as: hydrogen, halogen, trifluoromethyl, trifluoromethoxy, linear or branched C1-C4 alkyl, or linear or branched C1-C4 alkoxy, A represents oxygen or sulphur, B represents nitrogen when n=1 or 2 and D represents —C(═O)—, or B represents CH when n=0 and D represents —CH2O— or when n=1 and D represents —O—, R2 represents a hydrogen, a methyl, a fluorine or chlorine atom or a methoxy, HetAr represents a pyridyl or quinolyl group, possibly substituted by a group such as a linear or branched C1-C4 alkyl, a linear or branched C1-C4 alkoxy, a halogen, or a trifluoromethyl, and to their pharmaceutically acceptable salts.

DERIVATIVES OF HETEROARYLSULFONAMIDES, THEIR PREPARATION AND THEIR APPLICATION IN HUMAN THERAPY

The present invention concerns derivatives of heteroarylsulfonamides, notably as blockers of Kv potassium channels, and more particularly of channels Kv1.5, Kv4.3 or Kv11.1, their application in clinical therapy and their preparation methods. These compounds correspond to the following general formula (I): where R1 represents one or more substituents of the phenyl core X such as: hydrogen, halogen, trifluoromethyl, trifluoromethoxy, linear or branched C1-C4 alkyl, or linear or branched C1-C4 alkoxy, A represents oxygen or sulphur, B represents nitrogen when n=1 or 2 and D represents ?C(=O)-, or B represents CH when n=0 and D represents ?CH2O? or when n=1 and D represents ?O?, R2 represents a hydrogen, a methyl, a fluorine or chlorine atom or a methoxy, HetAr represents a pyridyl or quinolyl group, possibly substituted by a group such as a linear or branched C1-C4 alkyl, a linear or branched C1-C4 alkoxy, a halogen, or a trifluoromethyl, and to their pharmaceutically acceptable salts.

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

This invention relates to certain aryl alkyl acid compounds, compositions, and methods for treating or preventing obesity and related diseases.

Synthesis and Identification of 4-Methyl-N-(4H-1,2,4-triazol-4-yl)-2-benzothiazolamine, an Impurity in the Synthesis of Tricyclazole

The synthesis of 4-methyl-N-(4H-1,2,4-triazol-4-yl)-2-benzothiazolamine, 4, a by-product in the synthesis of tricyclazole, 1, by oxidative cyclization of the corresponding thiourea, 12, with thionyl chloride, is described.